Literature DB >> 16907927

Increased susceptibility of cord blood B lymphocytes to undergo spontaneous apoptosis.

A Kessel1, D Yehudai, R Peri, E Pavlotzky, E Bamberger, N Tov, E Toubi.   

Abstract

In this study, we compared the rate of spontaneous apoptosis of B cells from umbilical cord blood with adult B cells and assessed the role of Bcl-2, CD5, interleukin (IL)-4 and B cell-activating factor in B cell spontaneous apoptosis. We found that spontaneous apoptosis of cultured B cells, as assessed by utilizing annexin-V binding, was significantly higher in cord blood than in healthy adult individuals (77.5; 95 CI, 73.5-81.5 versus 59.2; 95 CI, 54-64, respectively, P < 0.0001) and further confirmed by 4' 6-diamidino-2-phenylindole, dihydrochloride (DAPI) staining. Whereas the expression of B cell-activating factor from the tumour necrosis factor family (BAFF) receptor mRNA was similar in B cells from adults and cord blood, we detected lower levels of circulating BAFF in the serum of cord blood (0.68 +/- 0.13 ng versus 1.83 +/- 0.54 ng, P = 0.01). The latter may explain, in part, our observation of lower levels of mean fluorescence intensity of Bcl-2 in cord B cells compared with adults (1.6 +/- 0.9 versus 2.85 +/- 1.3, P = 0.033). CD19(+) CD5(+) B cells from cord blood underwent a lower rate of apoptosis in comparison to CD19(+) CD5(-) B cells (25.1 +/- 9.3%versus 58.5 +/- 12.5%, P < 0.0001). This pattern of sensitivity was comparable in adult blood (15 +/- 5.5%versus 22.7 +/- 9.3%, P = 0.01). Nevertheless, the rate of apoptosis was higher in CD19(+) CD5(+) from cord blood compared to CD19(+) CD5(+) from adults (25.1 +/- 9.3%versus 15 +/- 5.5%, P = 0.0013). The addition of rIL-4 (10 u/ml) to cultured cells decreased B cell apoptosis in a similar fashion in both cord and adults blood. This rescue was strengthened when BAFF (100 microg/ml) was further added. Thus, alterations in Bcl-2 or serum BAFF level may explain the increased rate of cord blood B cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16907927      PMCID: PMC1809710          DOI: 10.1111/j.1365-2249.2006.03170.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

Review 1.  The biochemistry of apoptosis.

Authors:  M O Hengartner
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

2.  BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF.

Authors:  J S Thompson; S A Bixler; F Qian; K Vora; M L Scott; T G Cachero; C Hession; P Schneider; I D Sizing; C Mullen; K Strauch; M Zafari; C D Benjamin; J Tschopp; J L Browning; C Ambrose
Journal:  Science       Date:  2001-08-16       Impact factor: 47.728

3.  Coexistent naïve phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood.

Authors:  Paul Szabolcs; Kyung-Duk Park; Melissa Reese; Luciana Marti; Gloria Broadwater; Joanne Kurtzberg
Journal:  Exp Hematol       Date:  2003-08       Impact factor: 3.084

4.  Neonatal neutrophils with prolonged survival exhibit enhanced inflammatory and cytotoxic responsiveness.

Authors:  Joyce M Koenig; Joseph J Stegner; Alison C Schmeck; Matthew A Saxonhouse; Lisa E Kenigsberg
Journal:  Pediatr Res       Date:  2005-01-05       Impact factor: 3.756

5.  CD5-positive and CD5-negative human B cells converge to an indistinguishable population on signalling through B-cell receptors and CD40.

Authors:  A Gagro; N McCloskey; A Challa; M Holder; G Grafton; J D Pound; J Gordon
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

6.  Interleukin-4-mediated protection of primary B cells from apoptosis through Stat6-dependent up-regulation of Bcl-xL.

Authors:  Andrea L Wurster; Vikki L Rodgers; Morris F White; Thomas L Rothstein; Michael J Grusby
Journal:  J Biol Chem       Date:  2002-05-22       Impact factor: 5.157

7.  Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production.

Authors:  Hélène Gary-Gouy; Julie Harriague; Georges Bismuth; Cornelia Platzer; Christian Schmitt; Ali H Dalloul
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113

8.  Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response.

Authors:  R K Do; E Hatada; H Lee; M R Tourigny; D Hilbert; S Chen-Kiang
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

9.  CD5 maintains tolerance in anergic B cells.

Authors:  K L Hippen; L E Tze; T W Behrens
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

10.  Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells.

Authors:  Leonid Gorelik; Kevin Gilbride; Max Dobles; Susan L Kalled; Daniel Zandman; Martin L Scott
Journal:  J Exp Med       Date:  2003-09-15       Impact factor: 14.307

View more
  4 in total

1.  HIV, Cytomegalovirus, and Malaria Infections during Pregnancy Lead to Inflammation and Shifts in Memory B Cell Subsets in Kenyan Neonates.

Authors:  Kee Thai Yeo; Paula Embury; Timothy Anderson; Peter Mungai; Indu Malhotra; Christopher King; James Kazura; Arlene Dent
Journal:  J Immunol       Date:  2019-01-23       Impact factor: 5.422

2.  Replacing mouse BAFF with human BAFF does not improve B-cell maturation in hematopoietic humanized mice.

Authors:  Julie Lang; Bicheng Zhang; Margot Kelly; Jacob N Peterson; Jacob Barbee; Brian M Freed; James P Di Santo; Jennifer L Matsuda; Raul M Torres; Roberta Pelanda
Journal:  Blood Adv       Date:  2017-12-19

Review 3.  The challenge of assessing infant vaccine responses in resource-poor settings.

Authors:  Katie L Flanagan; Sarah Burl; Barbara L Lohman-Payne; Magdalena Plebanski
Journal:  Expert Rev Vaccines       Date:  2010-06       Impact factor: 5.217

4.  A longitudinal study of plasma BAFF levels in mothers and their infants in Uganda, and correlations with subsets of B cells.

Authors:  Caroline Rönnberg; Allan Lugaajju; Anna Nyman; Ulf Hammar; Matteo Bottai; Maximilian Julius Lautenbach; Christopher Sundling; Fred Kironde; Kristina E M Persson
Journal:  PLoS One       Date:  2021-01-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.